Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWAP feasibility study of inhaled corticosteroid withdrawal in mild to moderate COPD
2016-001876-31Phase 4Unknown
- Sponsor
- King's College London
- Start
- Aug 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of fluticasone propionate, fluticasone, budesonide and beclomethasone dipropionate in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by King's College London. Status: unknown.
02
Drugs
fluticasone propionatefluticasonebudesonidebeclomethasone dipropionate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2016-001876-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001876-31.